Visalytics
Visalytics
approved EB-2 (NIW)

Assistant Director

Medicinal Chemistry · China · 2021-08-25

Processing Time
320 days
Decision Date
2021-08-25
Location
Pennsylvania
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner intends to continue research focused on designing and synthesizing drug candidates to treat infectious diseases, CNS disorders, and cancers. Specifically, the work involves developing novel chemical entities for treating lung cancer, Parkinson’s disease, multiple myeloma, COVID-19, malaria, and tuberculosis.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses high-incidence diseases like tuberculosis and malaria, which is fundamental to the well-being of Americans and global health.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 7 publications, 134 citations, and 3 federal grants proves he is well-positioned to continue his medicinal chemistry research.

3 Waiver of Job Offer and Labor Certification Met

On balance, it is beneficial to the U.S. to waive the requirements to allow the petitioner to provide functional solutions to increasing drug resistance.

Why This Petition Was Approved

The petition was approved based on 7 peer-reviewed journal articles and 1 book chapter which accumulated 134 citations. The petitioner also demonstrated expertise through 8 completed peer reviews and the receipt of 3 separate funding grants from the NIH and USAMRDC, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Software Engineer

Artificial Intelligence · India

WeGreened EB-2 (NIW) approved
California 111 days 2026-12-13
The petitioner proposes to develop AI-driven activity monitoring methods for quality assurance in large-scale digital systems. The work focuses on identifying risks earlier and improving reliability to reduce costly disruptions across complex software platforms.
View Case

Management Consultant

Information Technology

WeGreened EB-2 (NIW) approved
2026-03-15
The petitioner proposes to continue their work in enterprise technology transformation, governance, and large-scale operational strategy. The work focuses on enhancing enterprise resilience, cybersecurity alignment, and digital transformation within major organizations to improve high-stakes operational settings.
View Case

Researcher

Healthcare

WeGreened EB-2 (NIW) approved
3 days 2026-03-02
The petitioner proposes to combine advanced clinical training with research to improve minimally invasive and reconstructive approaches for complex facial and nerve injuries. The work focuses on reducing downstream functional impairment and the overall care burden for patients.
View Case

Others

Information Technology · China

WeGreened EB-2 (NIW) approved
317 days 2026-02-21
The petitioner proposes to develop advanced deep learning models to improve the understanding of structure-function relationships in large biomolecules. This work aims to enable more accurate target identification, better candidate design, and more efficient therapeutic optimization for complex diseases. The endeavor specifically targets bottlenecks in drug development to reduce the high failure rate and cost of new drug candidates.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2021-08-25.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 320 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,967
Success Rate 55.1%
Sustained 2,184
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist